4th Annual Neuropsychiatric Drug Development Summit | September 28-30, 2021 | Digital

Temas de la conferencia
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/791022-3?pid=4832

Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more

https://go.evvnt.com/791022-2?pid=4832

Mr. Customer Service